We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HPR
6326
DELISTED
HighPoint Resources Corporation
HPR
-6,135
Closed -$33K
HMSY
6327
DELISTED
HMS Holdings Corp.
HMSY
-11,997
Closed -$444K
SYNC
6328
DELISTED
Synacor, Inc.
SYNC
-200
Closed
FBSS
6329
DELISTED
Fauquier Bankshares Inc
FBSS
-64
Closed -$1K
OTEL
6330
DELISTED
Otelco, Inc. Class A
OTEL
-189
Closed -$2K
GEN
6331
DELISTED
Genesis Healthcare, Inc.
GEN
-5,910
Closed -$2K
CEL
6332
DELISTED
Cellcom Israel, Ltd.
CEL
-141
Closed -$1K
WSG
6333
DELISTED
Wanda Sports Group Company Limited American Depositary Shares
WSG
-101
Closed
HUSN
6334
DELISTED
Hudson Capital Inc. Ordinary Shares
HUSN
-309
Closed -$2K
ZOM
6335
DELISTED
Zomedica Corp.
ZOM
-87,793
Closed -$139K
JE
6336
DELISTED
Just Energy Group Inc
JE
-8,236
Closed -$11K
SUMR
6337
DELISTED
Summer Infant, Inc.
SUMR
-49
Closed -$1K
BLPH
6338
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
-2,131
Closed -$11K
CFRX
6339
DELISTED
ContraFect Corporation
CFRX
-377
Closed -$144K
WTRU
6340
DELISTED
Essential Utilities, Inc.6.00% Tangible Equity Units
WTRU
-838
Closed -$48K
IDXG
6341
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
-177
Closed -$1K
TCF
6342
DELISTED
TCF Financial Corporation Common Stock
TCF
-14,858
Closed -$690K
NAVB
6343
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
-783
Closed -$2K
ICON
6344
DELISTED
Iconix Brand Group, Inc.
ICON
-129
Closed
NVIV
6345
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
-10
Closed
MACK
6346
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
-2,579
Closed -$16K
CBPO
6347
DELISTED
China Biologic Products Holdings, Inc.
CBPO
-177
Closed -$21K
CDOR
6348
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
$0 ﹤0.01%
76
-1,548
-95% -$6.67K
IO
6349
DELISTED
ION Geophysical Corporation
IO
-9,833
Closed -$21K
CIZ
6350
DELISTED
VictoryShares Developed Enhanced Volatility Wtd ETF
CIZ
$0 ﹤0.01%
2

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.